Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
Clinical trial NCT03737110 · COMPLETED
Trial details
- NCT number
- NCT03737110
- Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2020-05-29
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.